This study reveals relevant findings relating to current practice patterns for high-risk prostate cancer patients post-RP and confirms urologists' proclivity for not only increased salvage treatment at the point of BCR but also increased intensification of treatment when compared to the adjuvant setting. This evidence concerns the gene BCR and prostate carcinoma.